ALLMedicine™ Bronchitis Center

Dec 2nd, 2022 - Information about the direct comparability of big data of epidemiological cohort studies and the general population still is lacking, especially regarding all-cause mortality rates. The aim of this study was to investigate the overall survival and...

Nov 29th, 2022 - Alzheimer's disease (AD) patients rank among the highest levels of comorbidities compared to persons with other diseases. However, it is unclear whether the conditions are caused by shared pathophysiology due to the genetic pleiotropy for AD risk ...

Nov 28th, 2022 - We aimed to generate comprehensive estimates of the appropriateness of outpatient antibiotic prescriptions at primary healthcare facilities (PHFs) in China. We collected outpatient-visit prescriptions between 2017 and 2019 from 269 Chinese PHFs in...

Nov 28th, 2022 - Medicinal plants belonging to the genus Mimosa, such as Mimosa tenuiflora, M. caesalpinifolia, and M. verrucosa are known for their popular use for asthma, bronchitis and fever. Ethnopharmacological studies report that Mimosa acutistipula is used ...

Nov 27th, 2022 - Background: Social inequalities (e.g., poverty and low level of education) generate inequalities in health. Aim: The aim of the study was to determine the relationships between indicators of social inequalities and the frequency of respiratory sym...

Nov 20th, 2021 - Chronic cough is defined by a duration lasting at least 8 weeks. The most common causes of chronic cough include smoking-related lung disease, upper airway cough syndrome, asthma, gastroesophageal reflux disease, and nonasthmatic eosinophilic bron...

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Feb 28th, 2020 - Chronic cough due to chronic bronchitis (CB) causes significant impairment in quality of life, and effective treatment strategies are needed. We conducted a systematic review on the management of chronic cough due to CB to update the recommendatio...

Feb 25th, 2020 - Evidence for the diagnosis and management of cough due to acute bronchitis in immunocompetent adult outpatients was reviewed as an update to the 2006 "Chronic Cough Due to Acute Bronchitis: American College of Chest Physicians (ACCP) Evidence-Base...

Jan 24th, 2020 - Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults. We sought to determine the role of non-invasive measurements of airway inflammation, including induced sputum and fractional exhaled...

Oct 13th, 2022 - Chronic obstructive pulmonary disease (COPD), a term describing emphysema and chronic bronchitis, is the third leading cause of death in the United States, with approximately 24 million US adults estimated to have the disease and over 130,000 US a...

Oct 12th, 2022 - Within the scope of this non-interventional observational study, the quality of life of rhinosinusitis patients under self-medication with the 1,8 - cineole preparation Sinolpan® or Sinolpan® forte (Sinolpan® group) or with a nasally applied α-sym...

Oct 7th, 2022 - Rationale and background Roflumilast is licensed (i) for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis (CB) in adult patients with...

Oct 6th, 2022 - This study will be a multiregional (Europe, U.S., and Asia) multi-center, open-label study with 3-group, parallel preference design (Cigarette, THS use, and Smoking Abstinence). Subjects will self-select their group allocation according to their p...

Sep 30th, 2022 - Study D9180C00002 is a Phase II, randomised, double-blind, placebo-controlled, parallel group, proof of concept study to evaluate the efficacy and safety of MEDI3506 in adult participants with moderate to severe Chronic Obstructive Pulmonary Disea...

Aug 27th, 2022 - The addition of isatuximab-irfc (Sarclisa) to pomalidomide (Pomalyst) and low-dose dexamethasone (Isa-Pd) continued to demonstrate improved overall survival (OS) vs Pd alone in patients with relapsed/refractory multiple myeloma (RRMM), according t...

Aug 19th, 2022 - Switching from intravenous to subcutaneous infliximab (Remicade) was safe and effective for patients with inflammatory bowel disease (IBD) in clinical remission, an observational study in France showed. Among 133 patients treated with an intraveno...

Aug 10th, 2022 - Women Receive Unnecessary Medical Practices More Often Than Do Men "Low-value" medical indications that are considered unnecessary and potentially more harmful are performed more frequently in women than in men, according to a new Spanish study. L...

Aug 9th, 2022 - BUENOS AIRES, Argentina — Various "low-value" medical indications or practices that are considered futile, unnecessary, and potentially more harmful are performed more frequently in women than in men, according to a Spanish study. Examples of such...

Jul 27th, 2022 - The FDA expanded the approval of belimumab (Benlysta) to include treatment of pediatric patients with active lupus nephritis, drugmaker GSK announced on Wednesday. Already approved in adults with lupus nephritis, belimumab's new indication is spec...